Журнал микробиологии, эпидемиологии и иммунобиологии. 2018; : 84-92
ПРИМЕНЕНИЕ РЕАКЦИИ ЛАТЕКС-АГГЛЮТИНАЦИИ НА ОСНОВЕ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ДЛЯ ОБНАРУЖЕНИЯ И ИДЕНТИФИКАЦИИ ВОЗБУДИТЕЛЯ МЕЛИОИДОЗА В ПРОБАХ С ОБЪЕКТОВ ВНЕШНЕЙ СРЕДЫ И БИОЛОГИЧЕСКОГО МАТЕРИАЛА
Храпова Н. П., Меринова Л. К., Замарина Т. В., Фролов Д. М., Сенина Т. В., Корсакова И. И.
https://doi.org/10.36233/0372-9311-2018-1-84-92Аннотация
Список литературы
1. Илюхин В.И., СенинаТ.В., Плеханова Н.Г., Антонов В.А., Меринова Л.К., Сеимова И.К. Burkholderia thailandensis: биологические свойства, идентификация и таксономическая позиция. Мол. генет., микробиол. и вирусол. 2002, 1:7-11.
2. Лабораторная диагностика опасных инфекционных болезней. Практическое руководство. Г.Г.Онищенко, В.В.Кутырев (ред.). М., ЗАО «Шико», 2013.
3. Специфическая индикация патогенных биологических агентов: Практическое руководство. Г.Г.Онищенко, В.В.Кутырев (ред.). Саратов, ООО «Буква», 2014.
4. Amomchai Р., Chierakul W., Wuthiekanun V. et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J. Clin. Microbiol. 2007,45 (11): 3774-3776.
5. Anuntagool N., Naigowit P, Petkanchanapong V. et al. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J. Med. Microbiol. 2000,49 (12): 1075-1078.
6. Anuntagool N., IntachoteP,WuthiekanumV.etal. Lipopolysaccharide from nvirulent Ara+ Burkholderia pseudomallei isolates in immunologically indistinguishable from lipopolysaccharide from virulent Ara' clinical isolates. Clin. Diagn. Lab. Immunol. 1998, 5 (2): 225-229.
7. Anuntagool N., Intachote P., Naigowit P et al. Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection. J. Clin. Microbiol. 1996, 34 (4): 975976. ,.
8. Anuntagool N., Panichakul T, Aramsri P. et al. Shedding of lipopolysaccharide and 200-kDa surface antigen during the in vivo growth of virulent Ara- and avirulent Ara+ Burkholderia pseudomallei. Acta. Trop. 2000, 74 (2-3): 221-228.
9. Bossi P, Guihot A., Bricare F. Emerging or re-emerging infections that can be used for bioterrorism. Presse Med. 2005, 34 (2 Pt 2): 149-155.
10. Chaowagul W., White N.J., Dance D.A. et al. Melioidosis: a major cause ofcommunity acquired septicemia in northeastern Tailand. J. Infect. Dis. 1989,159 (5): 890-899.
11. Currie B.J., Dance D.A., Cheng A.C. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 2008, 102 (1): 1-4.
12. Currie B.J., Fisher D.A., Howard D.M. etal. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 2000, 31 (4): 981986.
13. Dance D.A. Melioidosis as an emerging global problem. Acta. Trop. 2000, 74 (2-3): 115119.
14. DharakulT., Songsivilai S., SmithikarnS. et at Rapid identification of Burkholderia pseudomallei it blood aulfuans by latex agglutinating using lipnpnlysacaOpaide-spnaifia mngnalngrl anfibody. Am. J. Taop. Med. Hyg. 1999,61 (4): 658-662.
15. Duval U.D., Elaod M.G., Gee J.E. ef al. Evaluating of a lafex agglutination assay for the identification Burkholderia pseudomallei and Burkholderia mallei. Am. J. Taop. Med. Hyg. 2014, 90 (6): 1043-1046.
16. Ekpo a, Rungpania O U., Pongsunh 0. ef al. Use of protein-specific monoclonal antibody-based lafex agglutination for rapid diagnosis of Burkholderia pseudomallei infeation in patienfs with community-acquired septiaemia. Clin. Vaccine Immunol. 2007,14 (6): 811-812.
17. Gilad J., Schwartz D., Amsalem Y. Сlinical feptuaes and laboratory diagnosis of infeation with the potential bioterrorism agents Burkholderia mallei and Burkholderia pseueompllei. Inf. J. Uiomed. Oai. 2007, 3 (3): 144-152.
18. Inglis T.J., Mearritt A., Chidlow G. ef al. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J. Clin. Miaanbiol. 2005,43 (5): 2201-2206.
19. Jedudason M.V., Balaji V, Sirisinha S. ef al. Rapid idenfification of Burkholderia pseudomallei in blood culture supernatants by a coagglutination assay. Clin. Miaaobiol. Infeaf. 2005,11: 925-936.
20. Khan A.O., Levitt A.M., Oage M.J. Biological and chemical terrorism: strategic plan for pae-paredness and response. MMWR Reaomm. Rep. 2000,49 (RR-4): 1-14.
21. Lau S.K., Sridhar So Ho C.C. et al. Laboratory diagnosis of melioidosiss:past, present and future. Exp. Uiol. Med. 2015, 240: 742-751.
22. Pongsunk S., EkpoP., Dharakul T. Production of specific monoclonal antibodies fo Burkholderia pseudomallei and their diagnostic application. Asian Рас. J. Alleagy Immunol. 1996, 14 (1): 43-47.
23. Pongsunk S., Thirawattanasuk N. Piyasangthong N. et.al. Rapid identifiaction Burkholderia pseudomallei in blood cultures by a monoalonal antibody assay. J. Clin. Miaaobiol. 1999, 37 (11): 3662-3667.
24. Samosornsuk N., Lulitanond A., Saenla N. et. al. Shot report: evalution of a monoclonal antibody-based latex agglutination test for rapid diagnosis of septicemia melioidosis. Am. J. Taop. Med. Hyg. 1999, 61 (5): 735-737.
25. Sirisinha S., Anuntagool N., Intachote P. J. et al. Antigenic differences between clinical and enviromental isolates of Burkholderia pseudomallei. Miaaobiol. Immunol. 1998, 42 (11): 731-737.
26. Sirisinha S., Anuntagool N., Dharakul T. et al. Recent developments in laboratory diagnosis of melioidosis. Aafa Taop. 2000, 74 (2-3): 235-245.
27. Smith M.D., Wuthiekanun V, Walsh A.L. et al. Latex agglutination test for identification of Pseudomonas pseudomallei. J. Clin. PatOol. 1993,46: 374-375.
28. Smith M.D., Angus U.J., Wuthiekanun V. et al. Arabinose assimilation defines a nonviaulent biofyae of Burkholderia pseudomallei. Infeaf. Immun. 1997, 65 (10): 4319-4321.
29. Steinmetz I., Reganzerowski A., Brenneke U. et al. Rapid identifiacation of Burkholderia pseudomallei by latex agglutination based on an exopolyspaccharide-specific monoclonal antibody. J. Clin. Miaanbiol. 1999, 37 (1): 225-228.
30. Thephai C., Dharakul T, Smithikarn O. et al. Differentiation between non-virulent and virulent Burkholderia pseudomallei with monoclonal antibodies to the Ara+ and Ara- biotypes. Am. J. Taop. Med. Hyg. 2001, 65 (1): 10-12.
31. White N.J., Dance D.A., Chaowagul W. et al. Halving of mortality of severe melioidosis by ceftazidime. Lpnaet. 1989, 2 (8665): 697-701.
32. Wuthiekanun V., Anuntagool N., White N. et al. Shot report: a rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia yhailandensis. Am. J. Taop. Med. Hyg. 2002, 66 (6): 759-761.
33. Wuthiekanun V, Desakorn V, Wongsuvan G. et al. Rapid immunofluoaescenae microscopy for diagnosis of melioidosis. Clin. Diag. Lab. Immunol. 2005, 12: 555-556.
34. Wuthiekanun V, Smith M.D., Dance D.A. et al. Biochemical characteristics of clinical and environmental isolates of Pseudomonas pseudomallei. J. Med. Miaanbiol. 1996, 45: 408412.
Journal of microbiology, epidemiology and immunobiology. 2018; : 84-92
APPLICATION OF MONOCLONAL ANTIBODY-BASED LATEX AGGLUTINATION TEST FOR DETECTION AND IDENTIFICATION OF THE AGENT OF MELIOIDOSIS IN CLINICAL AND ENVIRONMENTAL OBJECTS
Khrapova N. P., Merinova L. K., Zamarina T. V., Frolov D. M., Senina T. V., Korsakova I. I.
https://doi.org/10.36233/0372-9311-2018-1-84-92Abstract
References
1. Ilyukhin V.I., SeninaT.V., Plekhanova N.G., Antonov V.A., Merinova L.K., Seimova I.K. Burkholderia thailandensis: biologicheskie svoistva, identifikatsiya i taksonomicheskaya pozitsiya. Mol. genet., mikrobiol. i virusol. 2002, 1:7-11.
2. Laboratornaya diagnostika opasnykh infektsionnykh boleznei. Prakticheskoe rukovodstvo. G.G.Onishchenko, V.V.Kutyrev (red.). M., ZAO «Shiko», 2013.
3. Spetsificheskaya indikatsiya patogennykh biologicheskikh agentov: Prakticheskoe rukovodstvo. G.G.Onishchenko, V.V.Kutyrev (red.). Saratov, OOO «Bukva», 2014.
4. Amomchai R., Chierakul W., Wuthiekanun V. et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J. Clin. Microbiol. 2007,45 (11): 3774-3776.
5. Anuntagool N., Naigowit P, Petkanchanapong V. et al. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J. Med. Microbiol. 2000,49 (12): 1075-1078.
6. Anuntagool N., IntachoteP,WuthiekanumV.etal. Lipopolysaccharide from nvirulent Ara+ Burkholderia pseudomallei isolates in immunologically indistinguishable from lipopolysaccharide from virulent Ara' clinical isolates. Clin. Diagn. Lab. Immunol. 1998, 5 (2): 225-229.
7. Anuntagool N., Intachote P., Naigowit P et al. Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection. J. Clin. Microbiol. 1996, 34 (4): 975976. ,.
8. Anuntagool N., Panichakul T, Aramsri P. et al. Shedding of lipopolysaccharide and 200-kDa surface antigen during the in vivo growth of virulent Ara- and avirulent Ara+ Burkholderia pseudomallei. Acta. Trop. 2000, 74 (2-3): 221-228.
9. Bossi P, Guihot A., Bricare F. Emerging or re-emerging infections that can be used for bioterrorism. Presse Med. 2005, 34 (2 Pt 2): 149-155.
10. Chaowagul W., White N.J., Dance D.A. et al. Melioidosis: a major cause ofcommunity acquired septicemia in northeastern Tailand. J. Infect. Dis. 1989,159 (5): 890-899.
11. Currie B.J., Dance D.A., Cheng A.C. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 2008, 102 (1): 1-4.
12. Currie B.J., Fisher D.A., Howard D.M. etal. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 2000, 31 (4): 981986.
13. Dance D.A. Melioidosis as an emerging global problem. Acta. Trop. 2000, 74 (2-3): 115119.
14. DharakulT., Songsivilai S., SmithikarnS. et at Rapid identification of Burkholderia pseudomallei it blood aulfuans by latex agglutinating using lipnpnlysacaOpaide-spnaifia mngnalngrl anfibody. Am. J. Taop. Med. Hyg. 1999,61 (4): 658-662.
15. Duval U.D., Elaod M.G., Gee J.E. ef al. Evaluating of a lafex agglutination assay for the identification Burkholderia pseudomallei and Burkholderia mallei. Am. J. Taop. Med. Hyg. 2014, 90 (6): 1043-1046.
16. Ekpo a, Rungpania O U., Pongsunh 0. ef al. Use of protein-specific monoclonal antibody-based lafex agglutination for rapid diagnosis of Burkholderia pseudomallei infeation in patienfs with community-acquired septiaemia. Clin. Vaccine Immunol. 2007,14 (6): 811-812.
17. Gilad J., Schwartz D., Amsalem Y. Slinical feptuaes and laboratory diagnosis of infeation with the potential bioterrorism agents Burkholderia mallei and Burkholderia pseueompllei. Inf. J. Uiomed. Oai. 2007, 3 (3): 144-152.
18. Inglis T.J., Mearritt A., Chidlow G. ef al. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J. Clin. Miaanbiol. 2005,43 (5): 2201-2206.
19. Jedudason M.V., Balaji V, Sirisinha S. ef al. Rapid idenfification of Burkholderia pseudomallei in blood culture supernatants by a coagglutination assay. Clin. Miaaobiol. Infeaf. 2005,11: 925-936.
20. Khan A.O., Levitt A.M., Oage M.J. Biological and chemical terrorism: strategic plan for pae-paredness and response. MMWR Reaomm. Rep. 2000,49 (RR-4): 1-14.
21. Lau S.K., Sridhar So Ho C.C. et al. Laboratory diagnosis of melioidosiss:past, present and future. Exp. Uiol. Med. 2015, 240: 742-751.
22. Pongsunk S., EkpoP., Dharakul T. Production of specific monoclonal antibodies fo Burkholderia pseudomallei and their diagnostic application. Asian Ras. J. Alleagy Immunol. 1996, 14 (1): 43-47.
23. Pongsunk S., Thirawattanasuk N. Piyasangthong N. et.al. Rapid identifiaction Burkholderia pseudomallei in blood cultures by a monoalonal antibody assay. J. Clin. Miaaobiol. 1999, 37 (11): 3662-3667.
24. Samosornsuk N., Lulitanond A., Saenla N. et. al. Shot report: evalution of a monoclonal antibody-based latex agglutination test for rapid diagnosis of septicemia melioidosis. Am. J. Taop. Med. Hyg. 1999, 61 (5): 735-737.
25. Sirisinha S., Anuntagool N., Intachote P. J. et al. Antigenic differences between clinical and enviromental isolates of Burkholderia pseudomallei. Miaaobiol. Immunol. 1998, 42 (11): 731-737.
26. Sirisinha S., Anuntagool N., Dharakul T. et al. Recent developments in laboratory diagnosis of melioidosis. Aafa Taop. 2000, 74 (2-3): 235-245.
27. Smith M.D., Wuthiekanun V, Walsh A.L. et al. Latex agglutination test for identification of Pseudomonas pseudomallei. J. Clin. PatOol. 1993,46: 374-375.
28. Smith M.D., Angus U.J., Wuthiekanun V. et al. Arabinose assimilation defines a nonviaulent biofyae of Burkholderia pseudomallei. Infeaf. Immun. 1997, 65 (10): 4319-4321.
29. Steinmetz I., Reganzerowski A., Brenneke U. et al. Rapid identifiacation of Burkholderia pseudomallei by latex agglutination based on an exopolyspaccharide-specific monoclonal antibody. J. Clin. Miaanbiol. 1999, 37 (1): 225-228.
30. Thephai C., Dharakul T, Smithikarn O. et al. Differentiation between non-virulent and virulent Burkholderia pseudomallei with monoclonal antibodies to the Ara+ and Ara- biotypes. Am. J. Taop. Med. Hyg. 2001, 65 (1): 10-12.
31. White N.J., Dance D.A., Chaowagul W. et al. Halving of mortality of severe melioidosis by ceftazidime. Lpnaet. 1989, 2 (8665): 697-701.
32. Wuthiekanun V., Anuntagool N., White N. et al. Shot report: a rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia yhailandensis. Am. J. Taop. Med. Hyg. 2002, 66 (6): 759-761.
33. Wuthiekanun V, Desakorn V, Wongsuvan G. et al. Rapid immunofluoaescenae microscopy for diagnosis of melioidosis. Clin. Diag. Lab. Immunol. 2005, 12: 555-556.
34. Wuthiekanun V, Smith M.D., Dance D.A. et al. Biochemical characteristics of clinical and environmental isolates of Pseudomonas pseudomallei. J. Med. Miaanbiol. 1996, 45: 408412.
События
-
Журнал «Концепт: Философия, религия, культура» принят в Scopus >>>
9 июл 2025 | 13:25 -
К платформе Elpub присоединился журнал «The BRICS Health Journal» >>>
10 июн 2025 | 12:52 -
Журнал «Неотложная кардиология и кардиоваскулярные риски» присоединился к Elpub >>>
6 июн 2025 | 09:45 -
К платформе Elpub присоединился «Медицинский журнал» >>>
5 июн 2025 | 09:41 -
НЭИКОН принял участие в конференции НИИ Организации здравоохранения и медицинского менеджмента >>>
30 мая 2025 | 10:32